Norwood, MA, United States of America

Praveen K Tadikonda

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 10.1

ph-index = 4

Forward Citations = 31(Granted Patents)


Company Filing History:


Years Active: 2008-2015

Loading Chart...
Loading Chart...
6 patents (USPTO):

Title: Praveen K Tadikonda: Innovator in Pharmaceutical Chemistry

Introduction

Praveen K Tadikonda is a notable inventor based in Norwood, MA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for various medical applications. With a total of six patents to his name, his work focuses on innovative solutions for treating a range of disorders.

Latest Patents

Among his latest patents, Tadikonda has developed Anilinopiperazine derivatives and methods of use thereof. This invention relates to novel Anilinopiperazine Derivatives of Formula (I), which are used in compositions for treating or preventing proliferative disorders, cancer, inflammation, arthritis, and several other conditions. Another significant patent involves 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors, which also addresses similar medical applications.

Career Highlights

Throughout his career, Praveen K Tadikonda has worked with prominent companies in the pharmaceutical industry, including Merck Sharp & Dohme Corporation and Schering Corporation. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Tadikonda has collaborated with several professionals in his field, including M Arshad Siddiqui and Lianyun Zhao. These collaborations have further enhanced his research and development efforts.

Conclusion

Praveen K Tadikonda is a distinguished inventor whose work in pharmaceutical chemistry has led to the development of innovative treatments for various medical conditions. His contributions continue to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…